1,128
Participants
Start Date
February 5, 2021
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2026
Remimazolam
Remimazolam is administered intravenously for anesthesia induction and maintenance. The dose and infusion rate is adjusted to maintain BIS value between 40 and 60. Analgesia is maintained with remifentanil and/or sufentanil. Muscle relaxation is maintained with rocuronium and/or cisatracurium. Sevoflurane inhalation is provided when considered necessary.
Propofol
Propofol is administered intravenously for anesthesia induction and maintenance. The dose and infusion rate is adjusted to maintain BIS value between 40 and 60. Analgesia is maintained with remifentanil and/or sufentanil. Muscle relaxation is maintained with rocuronium and/or cisatracurium. Sevoflurane is provided when considered necessary.
RECRUITING
Peking University First Hospital, Beijin
RECRUITING
Beijing Tsinghua Chang Gung Hospital, Beijing
RECRUITING
The Sixth Medical Center of PLA General Hospital, Beijing
RECRUITING
Guizhou Provincial People's Hospital, Guiyang
RECRUITING
Jiangsu Provincial People's Hospital, Nanjing
RECRUITING
Shanghai 10th People's Hospital, Shanghai
Beijing Tsinghua Chang Gung Hospital
OTHER
Navy General Hospital, Beijing
OTHER
Guizhou Provincial People's Hospital
OTHER
Jiangsu Provincial People's Hospital
OTHER
Shanghai 10th People's Hospital
OTHER
Peking University First Hospital
OTHER